Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Assets
Current Assets
Cash
Income tax receivable
Prepaid expenses
Cash and marketable securities held in Trust Account
Total Current Assets
Deferred offering costs
Cash and marketable securities held in Trust Account
Total Assets
Liabilities and Stockholders' Equity
Current Liabilities
Accrued expenses
Accounts payable and accrued expenses
Accrued offering costs
Income taxes payable
Promissory note - related party
Total Current Liabilities
Deferred underwriting fee payable
Total Liabilities
Common stock subject to possible redemption, 32,131,082 and 32,572,779 shares at redemption value at September 30, 2019 and December 31, 2018, respectively
Stockholders' Equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Common stock
Class A Common Stock
Class B Common Stock
Additional paid-in capital
Retained earnings
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support